Rathbones Group PLC Novartis Ag Transaction History

Rathbones Group PLC

$19.7 Billion
Q1 2025

A detailed history of Rathbones Group PLC transactions in Novartis Ag stock. As of the latest transaction made, Rathbones Group PLC holds 48,946 shares of NVS stock, worth $5.8 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

48,946

Previous 50,876 3.79%

Holding current value

$5.8 Million

Previous $4.95 Million 10.22%

% of portfolio

0.03%

Previous 0.03%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	SELL	$97.14 - $115.57 $187,480 - $223,050	-1,930 Reduced 3.79%	48,946 $5.46 Million
Q4 2024 Feb 13, 2025	SELL	$96.78 - $117.18 $515,547 - $624,217	-5,327 Reduced 9.48%	50,876 $4.95 Million
Q3 2024 Nov 13, 2024	SELL	$106.13 - $120.89 $197,083 - $224,492	-1,857 Reduced 3.2%	56,203 $6.46 Million
Q2 2024 Aug 09, 2024	SELL	$92.57 - $107.37 $149,407 - $173,295	-1,614 Reduced 2.7%	58,060 $6.18 Million
Q1 2024 May 14, 2024	SELL	$95.27 - $108.47 $197,304 - $224,641	-2,071 Reduced 3.35%	59,674 $5.77 Million
Q4 2023 Feb 13, 2024	SELL	$92.27 - $101.54 $282,069 - $310,407	-3,057 Reduced 4.72%	61,745 $6.23 Million
Q3 2023 Nov 13, 2023	BUY	$94.73 - $105.13 $397,676 - $441,335	4,198 Added 6.93%	64,802 $6.6 Million
Q2 2023 Aug 04, 2023	SELL	$92.52 - $104.91 $105,287 - $119,387	-1,138 Reduced 1.84%	60,604 $6.12 Million
Q1 2023 May 12, 2023	SELL	$80.03 - $92.81 $371,579 - $430,916	-4,643 Reduced 6.99%	61,742 $5.68 Million
Q4 2022 Feb 14, 2023	SELL	$75.55 - $92.52 $1.15 Million - $1.41 Million	-15,276 Reduced 18.71%	66,385 $6.02 Million
Q3 2022 Nov 03, 2022	SELL	$74.61 - $87.26 $161,530 - $188,917	-2,165 Reduced 2.58%	81,661 $6.21 Million
Q2 2022 Aug 12, 2022	SELL	$80.52 - $93.75 $505,665 - $588,750	-6,280 Reduced 6.97%	83,826 $7.09 Million
Q1 2022 May 11, 2022	SELL	$80.11 - $90.62 $236,404 - $267,419	-2,951 Reduced 3.17%	90,106 $7.91 Million
Q4 2021 Feb 10, 2022	SELL	$79.7 - $88.13 $114,927 - $127,083	-1,442 Reduced 1.53%	93,057 $8.14 Million
Q3 2021 Nov 04, 2021	SELL	$81.78 - $95.14 $17,419 - $20,264	-213 Reduced 0.22%	94,499 $7.73 Million
Q2 2021 Jul 30, 2021	SELL	$85.24 - $94.15 $148,829 - $164,385	-1,746 Reduced 1.81%	94,712 $8.64 Million
Q1 2021 May 14, 2021	SELL	$83.5 - $98.47 $87,591 - $103,295	-1,049 Reduced 1.08%	96,458 $8.25 Million
Q4 2020 Feb 11, 2021	SELL	$78.07 - $94.43 $140,291 - $169,690	-1,797 Reduced 1.81%	97,507 $9.21 Million
Q3 2020 Nov 13, 2020	SELL	$82.14 - $91.0 $29,816 - $33,033	-363 Reduced 0.36%	99,304 $8.64 Million
Q2 2020 Aug 07, 2020	SELL	$80.93 - $91.1 $26,059 - $29,334	-322 Reduced 0.32%	99,667 $8.71 Million
Q1 2020 May 04, 2020	SELL	$70.67 - $99.01 $2,826 - $3,960	-40 Reduced 0.04%	99,989 $8.24 Million
Q4 2019 Feb 11, 2020	BUY	$84.35 - $95.37 $96,327 - $108,912	1,142 Added 1.15%	100,029 $9.47 Million
Q3 2019 Nov 13, 2019	BUY	$85.54 - $94.26 $8.46 Million - $9.32 Million	98,887 New	98,887 $8.59 Million

Others Institutions Holding NVS

# of Institutions

1,523

Shares Held

142M

Call Options Held

1.63M

Put Options Held

1.82M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $255B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rathbones Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Rathbones Group PLC with notifications on news.

Account

Rathbones Group PLC Novartis Ag Transaction History